µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© V{;! vt~
wEENN_w
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© :S}!i?n
1¡¢Co-stimulators (or co-stimulating molecules) NR-d|`P;
2¡¢NK-kB ;NH5
L,
3¡¢Immunoglobulin superfamily ;vvO#3DWM
4¡¢antigen-presenting cell (APC) 3TqC.S5+
5¡¢death domain A<l8CWv[
6¡¢CCR and CXCR % eWzr
7¡¢Lectin (or mitogen) K,e"@
G
8¡¢Clusters of differentiation, CD) r2}u\U4>
9¡¢B7 family XL@i/5C[
10¡¢Cytotoxic T lymphocyte, CTL) `B
k7W]{L
11¡¢IL-15 and IL-15 receptor (IL-15R) 5ckL=q"+/
12¡¢MHC restriction j_*$Avy
13¡¢Affinity-chromatography t-Rfy`I3
14¡¢Cyctosprin A, CsA h\\fb[``
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) yQE|FbiA
WZO8|hY
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© S9
R(;
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 b"n8~Vd
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ OV3l)73?t
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ a5=8zO#%g
52?zBl`|
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© *I6z;.#
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ {Q],rv|;
ѪҺ²¡Ñ§×¨Òµ£º C(zgBk
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿